In human ALS participants recruited in our study, we found that dosing with primidone reduced the serum levels of RIPK1 and IL-8, which were significantly higher in ALS patients than that of healthy individuals. The gene discussed is RIPK1; the disease is amyotrophic lateral sclerosis.